Pharmaceutical

HomeAid Celebrates Milestone of Serving Over 1.4 Million People Nationwide

Building a Future Without Homelessness IRVINE, CA / ACCESS Newswire / July 31, 2025 / HomeAid, a leading national nonprofit…

5 months ago

LeBron James Legally Sourced Miami Heat NBA Finals Jersey Sells for $242K as MDCE’s Infinite Auctions Leads Industry Clean-Up

As the sports memorabilia world confronts fraud and chaos, Infinite Auctions (OTC Pink:MDCE) delivers ironclad provenance and authenticity-led by the…

5 months ago

The Longevity Centers of America Bringing Natural Wellness and Regenerative Care to Greenville, South Carolina

With the opening of a new clinic, The Longevity Centers of America is expanding its signature blend of natural healing…

5 months ago

Phase 1 Equity Announces Its Fifth Practice Addition Of The Year, Bringing On An Orthodontic Practice Located in California

Expanding Its Doctor-Led Network Focused on Clinical Excellence and Aligned Values CHICAGO, IL / ACCESS Newswire / July 31, 2025…

5 months ago

Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement

First sublingual pre-workout single-serving supplement that delivers 50mg of caffeine rapidly to the body, is now available to order via…

5 months ago

Ensysce Biosciences Advances Breakthrough Opioid With Built-In Overdose Protection Following Positive FDA Feedback

~ Productive FDA Meeting Highlights Path Toward Overdose Protection Labeling and 505(b)(2) Regulatory Strategy ~~ FDA and Ensysce Aligned on…

5 months ago

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

BURLINGTON, Mass., July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a…

5 months ago

CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen, a biopharmaceutical company pursuing novel treatments for patients impacted by some of…

5 months ago

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response…

5 months ago

Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD)…

5 months ago